200670 is the Korean stock ticker for Humedix, a KOSDAQ-listed Korean public company in Healthcare & Biopharma.
200670 is the Korean stock ticker for Humedix, a KOSDAQ-listed Korean public company in Healthcare & Biopharma. Business activity: Hyaluronic acid and PDRN research and development. Business activity: Pharmaceutical and medical device production. Product/service: Dermal fillers and osteoarthritis treatments. Product/service: Liztox botulinum toxin. Product/service: Prosan and Hi Eye ophthalmic products. Product/service: Prescription drugs. Product/service: Hyaluronic acid and PDRN active pharmaceutical ingredients. Product/service: Elravie Cosmetics.
This ticker has no publisher-linked research report in the current collection.
200670 is a Korean stock ticker that trades on KOSDAQ as a common share tracked by Korean Tickers with data.go.kr daily public data, DART filings, and USD reference values.
Humedix is classified by Korean Tickers under Healthcare & Biopharma, with official issuer and industry context shown on the company profile.
| Item | TTM 26 Q2 LTM / latest balance sheet | 26 Q2 Standalone quarter | 26 Q1 Standalone quarter | 2025 Annual | 2024 Annual | Change vs 2025 |
|---|---|---|---|---|---|---|
| Revenue | $128.90M ₩177.9B | $36.54M ₩50.4B | $29.36M ₩40.5B | $123.23M ₩170.1B | $117.30M ₩161.9B | +4.6% |
| Gross Profit | $58.01M ₩80.1B | $16.63M ₩23.0B | $13.11M ₩18.1B | $57.62M ₩79.5B | $54.35M ₩75.0B | +0.7% |
| Operating Income | $29.49M ₩40.7B | $8.47M ₩11.7B | $6.45M ₩8.9B | $30.67M ₩42.3B | $31.26M ₩43.1B | -3.9% |
| Net Income | $33.27M ₩45.9B | $1.77M ₩2.4B | $9.42M ₩13.0B | $37.53M ₩51.8B | $28.45M ₩39.3B | -11.3% |
| Cash & Equivalents | $33.81M ₩46.7B | $33.81M ₩46.7B | $36.30M ₩50.1B | $28.90M ₩39.9B | $79.94M ₩110.3B | +17.0% |
| Current Assets | $127.32M ₩175.7B | $127.32M ₩175.7B | $132.42M ₩182.7B | $129.89M ₩179.2B | $115.97M ₩160.0B | -2.0% |
| Receivables | $25.10M ₩34.6B | $25.10M ₩34.6B | $21.39M ₩29.5B | $21.21M ₩29.3B | $14.84M ₩20.5B | +18.3% |
| Inventory | $20.74M ₩28.6B | $20.74M ₩28.6B | $16.41M ₩22.6B | $15.50M ₩21.4B | $19.12M ₩26.4B | +33.8% |
| Total Assets | $242.49M ₩334.6B | $242.49M ₩334.6B | $245.25M ₩338.4B | $234.52M ₩323.6B | $180.98M ₩249.8B | +3.4% |
| Current Liabilities | $17.45M ₩24.1B | $17.45M ₩24.1B | $16.50M ₩22.8B | $14.93M ₩20.6B | $14.02M ₩19.4B | +16.8% |
| Total Liabilities | $19.20M ₩26.5B | $19.20M ₩26.5B | $20.17M ₩27.8B | $17.43M ₩24.1B | $15.38M ₩21.2B | +10.1% |
| Total Equity | $223.30M ₩308.2B | $223.30M ₩308.2B | $225.08M ₩310.6B | $217.09M ₩299.6B | $165.60M ₩228.5B | +2.9% |